Here, we present the first evidence that the expression of B7x, but not other co-inhibitory molecules, is induced by HDAC inhibitor treatment and is associated with HDAC inhibitor resistance in colorectal cancer. This evidence concerns the gene VTCN1 and colorectal cancer.